IceCure Medical Ltd (ICCM)
1.23
0.05 (4.68%)
At close: Jan 14, 2025, 3:59 PM
1.16
-5.59%
After-hours Jan 14, 2025, 04:36 PM EST
undefined% (undefined)
| Bid | 1.24 |
| Market Cap | 67.38M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.28 |
| PE Ratio (ttm) | -4.39 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 1.31 |
| Volume | 401,327 |
| Avg. Volume (20D) | 753,488 |
| Open | 1.34 |
| Previous Close | 1.18 |
| Day's Range | 1.21 - 1.34 |
| 52-Week Range | 0.48 - 1.57 |
| Beta | undefined |
About ICCM
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel....
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 26, 2021
Employees 71
Stock Exchange NASDAQ
Ticker Symbol ICCM
Website https://www.icecure-medical.com
Analyst Forecast
According to 2 analyst ratings, the average rating for ICCM stock is "Buy." The 12-month stock price forecast is $2.7, which is an increase of 119.51% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
IceCure Medical Ltd is scheduled to release its earnings on Apr 2, 2025,
before market opens.
Analysts project revenue of $1.07M, reflecting a -14.74% YoY shrinking and earnings per share of -0.07, making a 0.00% YoY.
Analysts project revenue of $1.07M, reflecting a -14.74% YoY shrinking and earnings per share of -0.07, making a 0.00% YoY.
2 months ago ·
Source
+18.18%
IceCure Medical shares are trading higher after th...
Unlock content with
Pro Subscription
4 months ago ·
Source
+18.18%
IceCure Medical shares are trading higher after the company reported better-than-expected Q2 financial results.
